Martingale Asset Management L P Sutro Biopharma, Inc. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$7.78 - $15.31 $238,200 - $468,746	-30,617 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$14.25 - $23.53 $436,292 - $720,418	30,617 New	30,617 $455,000
Q4 2020 Feb 10, 2021	SELL	$10.16 - $23.98 $524,357 - $1.24 Million	-51,610 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$7.44 - $13.15 $245,505 - $433,923	-32,998 Reduced 39.0%	51,610 $518,000
Q2 2020 Aug 10, 2020	BUY	$7.24 - $11.05 $612,561 - $934,918	84,608 New	84,608 $656,000

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $49.6M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.